Courts / Dublin / Report

Drug safety manager alleges 'cover-up' at pharma giant Roche's Irish arm

Date
2023-02-23
Stage
Charge Or Pretrial
Primary locality
Dublin
County
Dublin

Summary

Dr Bruno Seigle‑Murandi, a pharmacovigilance manager at Roche Products Ireland, alleged to the Workplace Relations Commission that Roche's Irish arm had distributed non‑compliant marketing literature with a commercial purpose. He claimed that after a 2019 review, some oncologists received letters instructing them to discard all Roche literature and to advise patients to visit the practice. Seigle‑Murandi said Roche retaliated against him when he raised the issue, alleging a cover‑up to protect marketing and medical departments. Roche denies retaliation and says it acted immediately, notifying the Health Products Regulatory Authority (HPRA), which closed its file in February 2020. Seigle‑Murandi was dismissed for gross misconduct after refusing to comply with an internal audit and sending confidential emails from a personal account. The case was adjourned to Friday.

Who, what, where, when and why

What: Report matter: Drug safety manager alleges 'cover-up' at pharma giant Roche's Irish arm. Procedural stage: charge_or_pretrial

When:

Why: Dr Seigle-Murandi said the criticism against him was coming from the "core team" involved with the regulatory matters, which he said had removed his original recommendation that the regulator recall the literature because he had patient safety concerns. CNI source report

Places mentioned

Secondary Mention

Topics

Drugs Stage Charge Or Pretrial

Related court reports

Read the original CNI report

Correction or retraction request

If a fact, identity, locality or legal outcome needs review, email the newsroom with this report's details prefilled.

Email a correction request